A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61K 31/505 (2006.01) C07D 213/74 (2006.01) C07D 213/75 (2006.01) C07D 239/42 (2006.01) C07D 401/12 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01) C07D 471/04 (2006.01)
Patent
CA 2323208
Pharmaceutically active compounds which inhibit the vitronectin receptor and are useful for the treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor, such as osteoporosis.
La présente invention concerne des composés pharmaceutiquement actifs inhibiteurs du récepteur de la vitronectine. Ces composés conviennent pour le traitement de l'inflammation, du cancer, et de troubles cardio-vasculaires tels que l'athérosclérose et la resténose. Ces composés conviennent également pour le traitement de maladies où intervient une résorption osseuse, et notamment l'ostéoporose.
Gleason John G.
Heerding Dirk
Manley Peter J.
Miller William H.
Samanen James M.
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
Vitronectin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitronectin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitronectin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1396920